Abstract
Cocaine has become a public health problem. Several studies have shown that cocaine addiction is associated with multiple cognitive damages, such as memory, inhibitory control, attention and executive functions. A French cohort of cocaine addicted patients was divided into two groups: CCU (Current cocaine users) and abstainers. Their cognitive abilities were compared to a control group and associations with clinical determinants were assessed. The CCU group and the abstainers had episodic memory, working memory and inhibitory control disabilities compared to the control group. Both the CCU and the abstainers group had the same cognitive abilities but their clinical determinants for these cognitive abilities differed. In the CCU group, exposure to cocaine seemed to have a negative impact on cognition especially inhibitory control, memory and impulsivity. In the abstainers group, craving and depression impeded cognition.
Keywords: Cocaine, cognition, memory, neuropsychological, inhibitory control, attention, executive function.
Current Pharmaceutical Design
Title:Clinical Determinants of Cognition Levels in French Cocaine Addicted Patients
Volume: 20 Issue: 25
Author(s): Michael Szprync, Michel Reynaud, Nadege Bordas and Laurent Karila
Affiliation:
Keywords: Cocaine, cognition, memory, neuropsychological, inhibitory control, attention, executive function.
Abstract: Cocaine has become a public health problem. Several studies have shown that cocaine addiction is associated with multiple cognitive damages, such as memory, inhibitory control, attention and executive functions. A French cohort of cocaine addicted patients was divided into two groups: CCU (Current cocaine users) and abstainers. Their cognitive abilities were compared to a control group and associations with clinical determinants were assessed. The CCU group and the abstainers had episodic memory, working memory and inhibitory control disabilities compared to the control group. Both the CCU and the abstainers group had the same cognitive abilities but their clinical determinants for these cognitive abilities differed. In the CCU group, exposure to cocaine seemed to have a negative impact on cognition especially inhibitory control, memory and impulsivity. In the abstainers group, craving and depression impeded cognition.
Export Options
About this article
Cite this article as:
Szprync Michael, Reynaud Michel, Bordas Nadege and Karila Laurent, Clinical Determinants of Cognition Levels in French Cocaine Addicted Patients, Current Pharmaceutical Design 2014; 20 (25) . https://dx.doi.org/10.2174/13816128113199990621
DOI https://dx.doi.org/10.2174/13816128113199990621 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Oxidative Stress in HIV Patients Receiving Antiretroviral Therapy
Current HIV Research Emerging Vascular Risk Factors in Women: Any Differences from Men?
Current Medicinal Chemistry Overview of Dietary Influences on Atherosclerotic Vascular Disease:Epidemiology and Prevention
Cardiovascular & Hematological Disorders-Drug Targets A Critical and Comprehensive Insight on Heme Oxygenase and Related Products Including Carbon Monoxide, Bilirubin, Biliverdin and Ferritin in Type-1 and Type-2 Diabetes
Current Pharmaceutical Design Eicosanoids in Prevention and Management of Diseases
Current Molecular Medicine Follicular Cysts: A Single Sign and Different Diseases. A View from Comparative Medicine
Current Pharmaceutical Design Heat Shock Proteins in Diabetes and Wound Healing
Current Protein & Peptide Science Lipid Metabolism and Relevant Disorders to Female Reproductive Health
Current Medicinal Chemistry Enteric Ecosystem Disruption in Autism Spectrum Disorder: Can the Microbiota and Macrobiota be Restored?
Current Pharmaceutical Design Amniotic Fluid Embolism: What Level of Scientific Evidence can be Drawn? A Systematic Review
Current Pharmaceutical Biotechnology The Biological Effects of Diagnostic Cardiac Imaging
Current Pharmaceutical Design Pharmacogenetics and Anaesthesiology
Current Pharmacogenomics Comparision of Clinical Findings with CTPA Findings in Pulmonary Embolism
Current Medical Imaging Role of Polyunsaturated Fatty Acids and Fatty Acid Binding Protein in the Pathogenesis of Schizophrenia
Current Pharmaceutical Design Is Technical-Grade Chlordane an Obesogen?
Current Medicinal Chemistry Membrane and Soluble Forms of Endoglin in Preeclampsia
Current Molecular Medicine Signs and Related Mechanisms of Ethanol Hepatotoxicity
Current Drug Abuse Reviews Oxidative Stress in Diabetic Nephropathy
Current Medicinal Chemistry Future Therapeutic Directions: New Medications and Insulin Delivery in a Changing World for Effective Diabetes Management
Current Drug Discovery Technologies Neonatal Fever in the Term Infant: Evaluation and Management Strategies
Current Pediatric Reviews